Physician profile
Patrick Dorothy
NPI 1265278923
$2,287.68
in general payments reported to CMS, 2019-2025
13 companies · $2,269 in 2025
The $2,269 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $18.26 · 2025: $2,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,824 · Education: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,823.72 |
| Education | $463.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $417.20 | 2025 | Tremfya |
| Ucb, INC. | $390.90 | 2024-2025 | Bimzelx, Cimzia |
| Sun Pharmaceutical Industries INC. | $345.84 | 2025 | |
| Lilly USA, LLC | $333.17 | 2025 | Taltz, Ebglyss |
| Leo Pharma INC. | $192.21 | 2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $147.97 | 2025 | |
| Eli Lilly and Company | $99.00 | 2025 | |
| Genzyme Corporation | $89.14 | 2025 | |
| Pfizer INC. | $78.79 | 2025 | |
| Abbvie INC. | $78.35 | 2025 | |
| Galderma Laboratories, L.P. | $68.71 | 2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $28.45 | 2025 | Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.95 | 2025 | Siliq, Jublia, Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dorothy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.